BRIEF-EMA Publishes Updates Product Information For COVID-19 Treatment Regkirona (Regdanvimab), With Increase In Its Approved Shelf Life

EMA:

* EMA: EMA PUBLISHED UPDATED PRODUCT INFORMATION FOR COVID-19 TREATMENT REGKIRONA (REGDANVIMAB), WITH AN INCREASE IN ITS APPROVED SHELF LIFE